EUTM file information

018680819

RGC


March 31, 2022

Trademark Summary

The trademark application RGC was filed by Regeneron Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 1, 2022, and it was registered by office on August 8, 2022 without any oppositions.

The application was filed in English (German was selected as the second language).


Goods And Services

  • The mark was filed in class 42 with Scientific research in the field of genetics, genetic engineering, genetic sequencing, disease modelling, pharmacogenomics, and precision medicine.
Trademarkers